EDGAR Filing Documents for 0001783165-21-000002

Form D/A - Notice of Exempt Offering of Securities: [Amend]

SEC Accession No. 0001783165-21-000002

Filing Date

2021-02-23

Accepted

2021-02-23 16:24:55

Documents

Effectiveness Date

2021-02-23

Items

Item 06b:
Item 3C: Investment Company Act Section 3(c)
Item 3C.7: Section 3(c)(7)

Document Format Files

Seq	Description	Document	Type	Size
1		primary_doc.html	D/A
1		primary_doc.xml	D/A	6167
	Complete submission text file	0001783165-21-000002.txt		7370

Mailing Address C/O ADJUVANT CAPITAL, L.P. 501 FIFTH AVENUE, SUITE 1404 NEW YORK NY 10017

Business Address C/O ADJUVANT CAPITAL, L.P. 501 FIFTH AVENUE, SUITE 1404 NEW YORK NY 10017 917-334-0724

Adjuvant Global Health Technology Fund, L.P. (Filer) CIK: 0001783165 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9
Type: D/A | Act: 33 | File No.: 021-345780 | Film No.: 21665846